David Gisselsson Nord MD, PhD

David Gisselsson Nord is professor of molecular pathology and runs a research group aiming to resolve mechanisms of cancer cell evolution (diversity) including its implications for biomarker reliability and chemotherapy resistance. He is also a clinically active perinatal and peadiatric pathologist with a background in clinical genetics.